US Bill For CBD Supplement Path Draws Mixed Industry Response
Executive Summary
Four major trade organizations applauded the introduction of HR 8179, which would remove statutory impediments to CBD’s lawful use in dietary supplements, subjecting CBD to the same requirements in place for any new dietary ingredient. The Natural Products Association, on the other hand, is calling the bill a misstep.
You may also be interested in...
CBD Regulation Bill Filed In US House Again; VMS In Pre-Tax Savings Accounts In First Senate Vote
Hemp-Derived CBD bill either provides exact solution US needs for lawful use of cannabinoids as dietary ingredients or falls well short, depending on the trade group. Legislation to expand health savings accounts to include vitamin, mineral and supplement products reached Senate floor vote before failing.
RWD Curtain Lifted On US Cannabinoids Information Gap, But Lawful Use Remains TBD
FDA gives directions on research needed for sufficiently robust “real world data” about non-drug products containing cannabinoids. While optimistic that real world data will help bridge information gap about the ingredients' safety, it’s also candid about the size of the gap.
In Year Made Unusual By COVID-19, Still More Unusual Consumer Health Claims Surface In US
An ultraviolet lamp marketer was dinged by industry self-regulation for COVID-19 claims; the largest US natural food grocery chain had one too many undeclared allergens for the FDA's liking; and warnings note cannabidiol-containing eye drops, nasal sprays and inhalers promoted with drug claims.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: